17-beta-estradiol

Interstitial Cystitis

Duke UniversityPhase 2Dormant

B

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 95/ 100

Competitive context

5 Active assets in the Interstitial Cystitis cohort.

Asset / Sponsor	Phase	Rating
LIDOCAINE Jocelyn Fitzgerald	Phase 3	BB
Gralise Shirley Ryan AbilityLab	Phase 4	B
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Jocelyn Fitzgerald	Phase 3	B
Amitriptyline Jocelyn Fitzgerald	Phase 3	B
ROSIPTOR Aquinox Pharmaceuticals (Canada) Inc.	Phase 3	B

View all 10 →

Same molecule, other indications

17-beta-estradiol is also rated in:

Turner SyndromeDormant

BBB

Indicative ·

76 / 100

Infertility, FemaleDormant

BBB

Indicative ·

75 / 100

HypogonadismDormant

BBB

Indicative ·

75 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.